About Us
Mustafa Nevzat İlaç San. A.Ş.
Mustafa Nevzat İlaç San. A.Ş. is a well-established company operating in the pharmaceutical sector since 1923, guiding the Turkish healthcare sector with four generations of management. We have taken over the legacy of our founders and are among the leading institutions in the sector with innovative and modern approaches.
In 2012, following our successful sale, we further expanded our influence in the healthcare sector by establishing İmuneks Farma, a pioneering company in the OTC field. Our company, which has undertaken the most original drug development projects in Turkey, holds numerous international patents in this area and is renowned for its continuous research and development efforts.
With a perspective aligned with the dynamic and innovative norms of the 21st century, we steer the drug development process by leveraging artificial intelligence technologies. In this context, with the new technology we developed, we began drug development efforts against Covid-19 in 2020, and our Phase 3 study was included in the Stanford Medicine database.
Following the process of Mustafa Nevzat's reinstatement, our company, moving confidently toward the future in line with its centennial vision since 2021, continues to make a difference in the healthcare sector with its rich history, innovative approach, and strong vision.
